171 related articles for article (PubMed ID: 10770739)
1. Evernimicin binds exclusively to the 50S ribosomal subunit and inhibits translation in cell-free systems derived from both gram-positive and gram-negative bacteria.
McNicholas PM; Najarian DJ; Mann PA; Hesk D; Hare RS; Shaw KJ; Black TA
Antimicrob Agents Chemother; 2000 May; 44(5):1121-6. PubMed ID: 10770739
[TBL] [Abstract][Full Text] [Related]
2. Evernimicin (SCH27899) inhibits both translation and 50S ribosomal subunit formation in Staphylococcus aureus cells.
Champney WS; Tober CL
Antimicrob Agents Chemother; 2000 Jun; 44(6):1413-7. PubMed ID: 10817686
[TBL] [Abstract][Full Text] [Related]
3. Effects of mutations in ribosomal protein L16 on susceptibility and accumulation of evernimicin.
McNicholas PM; Mann PA; Najarian DJ; Miesel L; Hare RS; Black TA
Antimicrob Agents Chemother; 2001 Jan; 45(1):79-83. PubMed ID: 11120948
[TBL] [Abstract][Full Text] [Related]
4. EmtA, a rRNA methyltransferase conferring high-level evernimicin resistance.
Mann PA; Xiong L; Mankin AS; Chau AS; Mendrick CA; Najarian DJ; Cramer CA; Loebenberg D; Coates E; Murgolo NJ; Aarestrup FM; Goering RV; Black TA; Hare RS; McNicholas PM
Mol Microbiol; 2001 Sep; 41(6):1349-56. PubMed ID: 11580839
[TBL] [Abstract][Full Text] [Related]
5. Avilamycin and evernimicin induce structural changes in rProteins uL16 and CTC that enhance the inhibition of A-site tRNA binding.
Krupkin M; Wekselman I; Matzov D; Eyal Z; Diskin Posner Y; Rozenberg H; Zimmerman E; Bashan A; Yonath A
Proc Natl Acad Sci U S A; 2016 Nov; 113(44):E6796-E6805. PubMed ID: 27791159
[TBL] [Abstract][Full Text] [Related]
6. 50S ribosomal subunit synthesis and translation are equivalent targets for erythromycin inhibition in Staphylococcus aureus.
Champney WS; Burdine R
Antimicrob Agents Chemother; 1996 May; 40(5):1301-3. PubMed ID: 8723490
[TBL] [Abstract][Full Text] [Related]
7. Binding and action of CEM-101, a new fluoroketolide antibiotic that inhibits protein synthesis.
Llano-Sotelo B; Dunkle J; Klepacki D; Zhang W; Fernandes P; Cate JH; Mankin AS
Antimicrob Agents Chemother; 2010 Dec; 54(12):4961-70. PubMed ID: 20855725
[TBL] [Abstract][Full Text] [Related]
8. Targeting the A site RNA of the Escherichia coli ribosomal 30 S subunit by 2'-O-methyl oligoribonucleotides: a quantitative equilibrium dialysis binding assay and differential effects of aminoglycoside antibiotics.
Abelian A; Walsh AP; Lentzen G; Aboul-Ela F; Gait MJ
Biochem J; 2004 Oct; 383(Pt 2):201-8. PubMed ID: 15294017
[TBL] [Abstract][Full Text] [Related]
9. Binding of novel macrolide structures to macrolides-lincosamides-streptogramin B-resistant ribosomes inhibits protein synthesis and bacterial growth.
Goldman RC; Kadam SK
Antimicrob Agents Chemother; 1989 Jul; 33(7):1058-66. PubMed ID: 2506804
[TBL] [Abstract][Full Text] [Related]
10. Retapamulin inhibition of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells.
Champney WS; Rodgers WK
Antimicrob Agents Chemother; 2007 Sep; 51(9):3385-7. PubMed ID: 17562806
[TBL] [Abstract][Full Text] [Related]
11. Macrolide antibiotic inhibition of translation and 50S ribosomal subunit assembly in methicillin-resistant Staphylococcus aureus cells.
Champney WS; Burdine R
Microb Drug Resist; 1998; 4(3):169-74. PubMed ID: 9818968
[TBL] [Abstract][Full Text] [Related]
12. Macrolide antibiotics inhibit 50S ribosomal subunit assembly in Bacillus subtilis and Staphylococcus aureus.
Champney WS; Burdine R
Antimicrob Agents Chemother; 1995 Sep; 39(9):2141-4. PubMed ID: 8540733
[TBL] [Abstract][Full Text] [Related]
13. Superiority of 11,12 carbonate macrolide antibiotics as inhibitors of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells.
Champney WS; Tober CL
Curr Microbiol; 1999 Jun; 38(6):342-8. PubMed ID: 10341075
[TBL] [Abstract][Full Text] [Related]
14. Neomycin and paromomycin inhibit 30S ribosomal subunit assembly in Staphylococcus aureus.
Mehta R; Champney WS
Curr Microbiol; 2003 Sep; 47(3):237-43. PubMed ID: 14570276
[TBL] [Abstract][Full Text] [Related]
15. Comparison of fortimicins with other aminoglycosides and effects on bacterial ribosome and protein synthesis.
Moreau N; Jaxel C; Le Goffic F
Antimicrob Agents Chemother; 1984 Dec; 26(6):857-62. PubMed ID: 6395800
[TBL] [Abstract][Full Text] [Related]
16. The binding of kasugamycin to the Escherichia coli ribosomes.
Okuyama A; Tanaka N; Komai T
J Antibiot (Tokyo); 1975 Nov; 28(11):903-5. PubMed ID: 1104550
[TBL] [Abstract][Full Text] [Related]
17. Ribosomal alterations contribute to bacterial resistance against the dipeptide antibiotic TAN 1057.
Limburg E; Gahlmann R; Kroll HP; Beyer D
Antimicrob Agents Chemother; 2004 Feb; 48(2):619-22. PubMed ID: 14742220
[TBL] [Abstract][Full Text] [Related]
18. Interaction of avilamycin with ribosomes and resistance caused by mutations in 23S rRNA.
Kofoed CB; Vester B
Antimicrob Agents Chemother; 2002 Nov; 46(11):3339-42. PubMed ID: 12384333
[TBL] [Abstract][Full Text] [Related]
19. The ketolide antibiotic ABT-773 is a specific inhibitor of translation and 50S ribosomal subunit formation in Streptococcus pneumoniae cells.
Champney WS; Pelt J
Curr Microbiol; 2002 Sep; 45(3):155-60. PubMed ID: 12177734
[TBL] [Abstract][Full Text] [Related]
20. Binding of erythromycin to the 50S ribosomal subunit is affected by alterations in the 30S ribosomal subunit.
Saltzman L; Apirion D
Mol Gen Genet; 1976 Feb; 143(3):301-6. PubMed ID: 765762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
